Bath & Body Works, Inc. (BBWI) steps up to the earnings podium Thursday morning, and Wall Street's sharpest analysts can't quite agree on what to expect next from the Columbus, Ohio-based retailer.
The company will release its third-quarter results before the opening bell on Thursday, November 20. Analysts are penciling in earnings of 40 cents per share, a decline from 49 cents in the same period last year. Revenue estimates sit at $1.63 billion, compared to $1.61 billion a year ago.
Recent Performance and Stock Movement
Bath & Body Works last reported earnings on August 28, delivering second-quarter fiscal 2025 net sales of $1.55 billion. That represented a 1.5% increase from the prior year's $1.53 billion and matched consensus estimates right on the nose.
Shares edged down 0.3% to close at $21.04 on Wednesday.
What the Most Accurate Analysts Are Saying
The recent analyst activity tells an interesting story about diverging opinions on Bath & Body Works' trajectory. Here's what Wall Street's most accurate forecasters have been saying:
Telsey Advisory Group analyst Dana Telsey maintained an Outperform rating with a $38 price target on November 13. Telsey carries a 61% accuracy rate.
Raymond James analyst Olivia Tong downgraded the stock from Outperform to Market Perform on November 12, removing her price target entirely. Tong's accuracy rate stands at 64%.
Morgan Stanley analyst Alex Straton maintained an Overweight rating and bumped the price target from $40 to $43 on November 5. Straton has a 64% accuracy rate.
Wells Fargo analyst Ike Boruchow kept an Overweight rating but slashed the price target from $44 to $33 on October 27. Boruchow boasts the highest accuracy rate in this group at 72%.
Barclays analyst Adrienne Yih maintained an Equal-Weight rating and cut the price target from $32 to $28 on October 20. Yih's accuracy rate is 67%.
The wide range of price targets and mixed rating actions suggest analysts are wrestling with competing signals about the retailer's outlook heading into the holiday season.